BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17298985)

  • 1. Periacinar retraction clefting in proliferative prostatic atrophy and prostatic adenocarcinoma.
    Ulamec M; Tomas D; Ensinger C; Cupic H; Belicza M; Mikuz G; Kruslin B
    J Clin Pathol; 2007 Oct; 60(10):1098-101. PubMed ID: 17298985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periacinar retraction clefting in the prostatic needle core biopsies: an important diagnostic criterion or a simple artifact?
    Kruslin B; Tomas D; Rogatsch H; Novosel I; Cupić H; Belicza M; Kraus O; Mikuz G
    Virchows Arch; 2003 Oct; 443(4):524-7. PubMed ID: 12898245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of periacinar retraction clefting in needle core biopsies and corresponding prostatectomy specimens of patients with prostatic adenocarcinoma.
    Kruslin B; Tomas D; Rogatsch H; Reljić A; Vucić M; Balicević D; Belicza M; Mikuz G
    Int J Surg Pathol; 2005 Jan; 13(1):67-72. PubMed ID: 15735857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periacinar retraction clefting in nonneoplastic and neoplastic prostatic glands: artifact or molecular involvement.
    Fávaro WJ; Hetzl AC; Reis LO; Ferreira U; Billis A; Cagnon VH
    Pathol Oncol Res; 2012 Apr; 18(2):285-92. PubMed ID: 21912906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic adenocarcinoma with atrophic features: a study of 202 consecutive completely embedded radical prostatectomy specimens.
    Kaleem Z; Swanson PE; Vollmer RT; Humphrey PA
    Am J Clin Pathol; 1998 Jun; 109(6):695-703. PubMed ID: 9620026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Relationship between E-Cadherin and β-Catenin Cell Adhesion Proteins and Periacinar Retraction Clefting in Prostatic Adenocarcinoma.
    Limani R; Lež C; Krušlin B
    Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process.
    Egan AJ; Lopez-Beltran A; Bostwick DG
    Am J Surg Pathol; 1997 Aug; 21(8):931-5. PubMed ID: 9255256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
    Shah R; Mucci NR; Amin A; Macoska JA; Rubin MA
    Am J Pathol; 2001 May; 158(5):1767-73. PubMed ID: 11337374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma.
    Cheville JC; Bostwick DG
    Am J Surg Pathol; 1995 Sep; 19(9):1068-76. PubMed ID: 7544958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different types of atrophy in the prostate with and without adenocarcinoma.
    Tomas D; Kruslin B; Rogatsch H; Schäfer G; Belicza M; Mikuz G
    Eur Urol; 2007 Jan; 51(1):98-103; discussion 103-4. PubMed ID: 16824675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periacinar retraction clefting and d2-40 expression in prostatic adenocarcinoma.
    Ulamec M; Džombeta T; Cupić H; Leniček T; Tomas D; Krušlin B
    Pathol Oncol Res; 2012 Apr; 18(2):365-70. PubMed ID: 21910091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periacinar Clefting and p63 Immunostaining in Prostatic Intraepithelial Neoplasia and Prostatic Carcinoma.
    Kruslin B; Tomas D; Cviko A; Cupic H; Odak L; Belicza M
    Pathol Oncol Res; 2006; 12(4):205-9. PubMed ID: 17189982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histology and cellular kinetics of prostatic atrophy.
    Ruska KM; Sauvageot J; Epstein JI
    Am J Surg Pathol; 1998 Sep; 22(9):1073-7. PubMed ID: 9737239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postatrophic hyperplasia of the prostate: lack of association with prostate cancer.
    Anton RC; Kattan MW; Chakraborty S; Wheeler TM
    Am J Surg Pathol; 1999 Aug; 23(8):932-6. PubMed ID: 10435563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microcystic adenocarcinoma of the prostate: a variant of pseudohyperplastic and atrophic patterns.
    Yaskiv O; Cao D; Humphrey PA
    Am J Surg Pathol; 2010 Apr; 34(4):556-61. PubMed ID: 20216381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia.
    Putzi MJ; De Marzo AM
    Urology; 2000 Nov; 56(5):828-32. PubMed ID: 11068311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
    Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
    Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrophy and proliferation in the young adult prostate.
    Gardner WA; Culberson DE
    J Urol; 1987 Jan; 137(1):53-6. PubMed ID: 2432282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.